SGLT2 Inhibitors Market

The SGLT2 Inhibitors Market is segmented by Drug (Jardiance (empagliflozin), Farxiga (dapagliflozin), Invokana (canagliflozin), Inpefa (sotagliflozin), Qtern (dapagliflozin/saxagliptin), and Other SGLT2 Inhibitors), Indication (Type 2 Diabetes, Cardiovascular Diseases, Chronic Kidney Disease (CKD), and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region. Forecast for 2026 to 2036.